Overview
Yongwei Su practices practicing medicine in Shenzhen, China.
Su is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Mitochondrial Complex 1 Deficiency, and Oral Cancer.
They are actively involved in clinical research, co-authoring 26 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yongwei K. Su
Is Yongwei K. Su a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Yongwei K. Su is classified as an Advanced expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yongwei K. Su participate in research or clinical trials?
Yes. Yongwei K. Su has published 26 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Yongwei K. Su's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)
- LeukemiaSu isAdvanced. Learn about Leukemia.
- Experienced
- Mitochondrial Complex 1 Deficiency
- Oral CancerSu isExperienced. Learn about Oral Cancer.